Cargando…
Targeting COX-2 potently inhibits proliferation of cancer cells in vivo but not in vitro in cutaneous squamous cell carcinoma
BACKGROUND: Cyclooxygenase 2 (COX-2) is an inducible enzyme which promotes tumorigenesis in many types of cancers. Genetic knockout of COX-2 significantly suppresses the tumorigenesis of skin squamous cell carcinoma (SCC). However, COX-2 inhibitor treatment only showed mild to moderate inhibition on...
Autores principales: | Gao, Lipeng, Wang, Tim Hua, Chen, Champ Peng, Xiang, Jan Jian, Zhao, Xu-Bo, Gui, Rong-Yin, Liao, Xin-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797700/ https://www.ncbi.nlm.nih.gov/pubmed/35116540 http://dx.doi.org/10.21037/tcr-20-3527 |
Ejemplares similares
-
Downregulation of lncRNA NEAT1 inhibits the proliferation of human cutaneous squamous cell carcinoma in vivo and in vitro
por: Gong, Zhenhua, et al.
Publicado: (2022) -
Effect of Hath1 on the proliferation and apoptosis of cutaneous squamous cell carcinoma in vitro
por: YING, ZUOLIN, et al.
Publicado: (2015) -
Plasma Treatment Limits Cutaneous Squamous Cell Carcinoma Development In Vitro and In Vivo
por: Pasqual-Melo, Gabriella, et al.
Publicado: (2020) -
Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
por: Hattar, Katja, et al.
Publicado: (2012) -
Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models
por: Quadri, Marika, et al.
Publicado: (2022)